A new research paper was published by Aging (Aging-US) on January 6, 2025, in Volume 17, Issue 1, titled “The profile of oxidative stress markers (arachidonic and linoleic acid derivatives) ...

A new research paper was published by Aging (Aging-US) on January 6, 2025, in Volume 17, Issue 1, titled "The profile of ...

Our research results suggest that pro-inflammatory mediators and suppressors of inflammation are involved in the development ...

Finasteride is used to treat benign prostatic hyperplasia. For a very few men, this causes pain in the breast tissue.

I am an 88-year-old male who has been taking tamsulosin twice daily for several years because of benign prostatic hyperplasia ...

Dear W.R.: Finasteride works by blocking the enzyme that converts regular testosterone to dihydrotestosterone (DHT). DHT is ...

The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion in 2024 and an ...

A newly published Danish study has evaluated the efficacy and safety of CoreTherm® in men with prostate sizes exceeding 100 grams. The median prostate size among participants was 126 g (range: 101-230 ...

In today’s fast-paced world, maintaining optimal health is paramount, especially for men who may face unique health ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ...